When a military judge ruled last month that Salim Ahmed Hamdan, a former driver for Osama bin Laden, could be tried for war crimes, the first footnote in his July 14 opinion (pdf) was to a Congressional Research Service report. (Hamdan was convicted yesterday for material support of terrorism.)
But Military Judge Keith J. Allred, lacking an official source for the CRS analysis by Jennifer K. Elsea (with which he ultimately differed), provided a link instead (see footnote 1 on page 3) to a copy of the document on the Federation of American Scientists web site.
By doing so, the Judge simultaneously highlighted the centrality of such CRS analyses to public discourse and the strange fact that these official documents are still not approved for direct release to the public.
Perhaps he also implicitly affirmed that FAS and other public interest publishers of CRS collections are helping to compensate for that continuing policy defect by providing the online access to CRS reports that Congress has denied.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.